aprosulate and dalteparin
aprosulate has been researched along with dalteparin in 2 studies
*Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed) [MeSH]
*Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed) [MeSH]
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Eckenberger, P; Fareed, J; Haas, S; Hoppensteadt, D; Jeske, W; Kammereit, A; Klauser, R; Wyld, P | 1 |
| Elling, H; Klauser, RJ; Meinetsberger, E; Raake, W; Zeiller, P | 1 |
Trials
1 trial(s) available for aprosulate and dalteparin
| Article | Year |
|---|---|
Effect of repeated Aprosulate and Enoxaparin administration on tissue factor pathway inhibitor antigen levels.
Topics: Analysis of Variance; Anticoagulants; Antigens; Disaccharides; Drug Administration Schedule; Enoxaparin; Humans; Lipoproteins; Male; Reference Values; Serine Proteinase Inhibitors | 1995 |
Other Studies
1 other study(ies) available for aprosulate and dalteparin
| Article | Year |
|---|---|
Derivatives of bis-aldonic acid amides and their anticoagulant and antithrombotic properties.
Topics: Animals; Anticoagulants; Bleeding Time; Disaccharides; Factor Xa Inhibitors; Fibrinolytic Agents; Heparin; Humans; Jugular Veins; Nadroparin; Partial Thromboplastin Time; Rats; Structure-Activity Relationship; Thrombosis | 1994 |